Skip to main content Skip to footer
HomeHome
 
  • Homepage
  • Searching for patents

    Patent knowledge

    Access our patent databases and search tools.

    Go to overview 

    • Overview
    • Technical information
      • Overview
      • Espacenet - patent search
      • European Publication Server
      • EP full-text search
    • Legal information
      • Overview
      • European Patent Register
      • European Patent Bulletin
      • European Case Law Identifier sitemap
      • Third-party observations
    • Business information
      • Overview
      • PATSTAT
      • IPscore
      • Technology insight reports
    • Data
      • Overview
      • Technology Intelligence Platform
      • Linked open EP data
      • Bulk data sets
      • Web services
      • Coverage, codes and statistics
    • Technology platforms
      • Overview
      • Digital agriculture
      • Plastics in transition
      • Water innovation
      • Space innovation
      • Technologies combatting cancer
      • Firefighting technologies
      • Clean energy technologies
      • Fighting coronavirus
    • Helpful resources
      • Overview
      • First time here?
      • Asian patent information
      • Patent information centres
      • Patent Translate
      • Patent Knowledge News
      • Business and statistics
      • Unitary Patent information in patent knowledge
    Image
    EPO TIR study-Agriculture-web-720 x 237

    Technology insight report on digital agriculture

  • Applying for a patent

    Applying for a patent

    Practical information on filing and grant procedures.

    Go to overview 

    • Overview
    • European route
      • Overview
      • European Patent Guide
      • Oppositions
      • Oral proceedings
      • Appeals
      • Unitary Patent & Unified Patent Court
      • National validation
      • Request for extension/validation
    • International route (PCT)
      • Overview
      • Euro-PCT Guide – PCT procedure at the EPO
      • EPO decisions and notices
      • PCT provisions and resources
      • Extension/validation request
      • Reinforced partnership programme
      • Accelerating your PCT application
      • Patent Prosecution Highway (PPH)
      • Training and events
    • National route
    • Find a professional representative
    • MyEPO services
      • Overview
      • Understand our services
      • Get access
      • File with us
      • Interact with us on your files
      • Online Filing & fee payment outages
    • Forms
      • Overview
      • Request for examination
    • Fees
      • Overview
      • European fees (EPC)
      • International fees (PCT)
      • Unitary Patent fees (UP)
      • Fee payment and refunds
      • Warning
      • Fee Assistant
      • Fee reductions and compensation

    UP

    Find out how the Unitary Patent can enhance your IP strategy

  • Law & practice

    Law & practice

    European patent law, the Official Journal and other legal texts.

    Go to overview 

    • Overview
    • Legal texts
      • Overview
      • European Patent Convention
      • Official Journal
      • Guidelines
      • Extension / validation system
      • London Agreement
      • National law relating to the EPC
      • Unitary patent system
      • National measures relating to the Unitary Patent
    • Court practices
      • Overview
      • European Patent Judges' Symposium
    • User consultations
      • Overview
      • Ongoing consultations
      • Completed consultations
    • Substantive patent law harmonisation
      • Overview
      • The Tegernsee process
      • Group B+
    • Convergence of practice
    • Options for representatives
    Image
    Law and practice scales 720x237

    Keep up with key aspects of selected BoA decisions with our monthly "Abstracts of decisions”

  • News & events

    News & events

    Our latest news, podcasts and events, including the European Inventor Award.

    Go to overview 

     

    • Overview
    • News
    • Events
    • European Inventor Award
      • Overview
      • About the award
      • Categories and prizes
      • Meet the finalists
      • Nominations
      • European Inventor Network
      • The 2024 event
    • Young Inventors Prize
      • Overview
      • About the prize
      • Nominations
      • The jury
      • The world, reimagined
      • The 2025 event
    • Press centre
      • Overview
      • Patent Index and statistics
      • Search in press centre
      • Background information
      • Copyright
      • Press contacts
      • Call back form
      • Email alert service
    • Innovation and patenting in focus
      • Overview
      • CodeFest
      • Green tech in focus
      • Research institutes
      • Lifestyle
      • Space and satellites
      • The future of medicine
      • Materials science
      • Mobile communications
      • Biotechnology
      • Patent classification
      • Digital technologies
      • The future of manufacturing
      • Books by EPO experts
    • "Talk innovation" podcast

    Podcast

    From ideas to inventions: tune into our podcast for the latest in tech and IP

  • Learning

    Learning

    The European Patent Academy – the point of access to your learning

    Go to overview 

    • Overview
    • Learning activities and paths
      • Overview
      • Learning activities
      • Learning paths
    • EQE and EPAC
      • Overview
      • EQE - European qualifying examination
      • EPAC - European patent administration certification
      • CSP – Candidate Support Programme
    • Learning resources by area of interest
      • Overview
      • Patent granting
      • Technology transfer and dissemination
      • Patent enforcement and litigation
    • Learning resources by profile
      • Overview
      • Business and IP managers
      • EQE and EPAC Candidates
      • Judges, lawyers and prosecutors
      • National offices and IP authorities
      • Patent attorneys and paralegals
      • Universities, research centres and technology transfer centres (TTOs)
    Image
    Patent Academy catalogue

    Have a look at the extensive range of learning opportunities in the European Patent Academy training catalogue

  • About us

    About us

    Find out more about our work, values, history and vision

    Go to overview 

    • Overview
    • The EPO at a glance
    • 50 years of the EPC
      • Overview
      • Official celebrations
      • Member states’ video statements
      • 50 Leading Tech Voices
      • Athens Marathon
      • Kids’ collaborative art competition
    • Legal foundations and member states
      • Overview
      • Legal foundations
      • Member states of the European Patent Organisation
      • Extension states
      • Validation states
    • Administrative Council and subsidiary bodies
      • Overview
      • Communiqués
      • Calendar
      • Documents and publications
      • Administrative Council
    • Principles & strategy
      • Overview
      • Our mission, vision, values and corporate policy
      • Strategic Plan 2028
      • Towards a New Normal
    • Leadership & management
      • Overview
      • President António Campinos
      • Management Advisory Committee
    • Sustainability at the EPO
      • Overview
      • Environmental
      • Social
      • Governance and Financial sustainability
    • Services & activities
      • Overview
      • Our services & structure
      • Quality
      • Consulting our users
      • European and international co-operation
      • European Patent Academy
      • Chief Economist
      • Ombuds Office
      • Reporting wrongdoing
    • Observatory on Patents and Technology
      • Overview
      • Technologies
      • Innovation actors
      • Policy and funding
      • Tools
      • About the Observatory
    • Procurement
      • Overview
      • Procurement forecast
      • Doing business with the EPO
      • Procurement procedures
      • Sustainable Procurement Policy
      • About eTendering and electronic signatures
      • Procurement portal
      • Invoicing
      • General conditions
      • Archived tenders
    • Transparency portal
      • Overview
      • General
      • Human
      • Environmental
      • Organisational
      • Social and relational
      • Economic
      • Governance
    • Statistics and trends
      • Overview
      • Statistics & Trends Centre
      • Patent Index 2024
      • EPO Data Hub
      • Clarification on data sources
    • History
      • Overview
      • 1970s
      • 1980s
      • 1990s
      • 2000s
      • 2010s
      • 2020s
    • Art collection
      • Overview
      • The collection
      • Let's talk about art
      • Artists
      • Media library
      • What's on
      • Publications
      • Contact
      • Culture Space A&T 5-10
      • "Long Night"
    Image
    Patent Index 2024 keyvisual showing brightly lit up data chip, tinted in purple, bright blue

    Track the latest tech trends with our Patent Index

 
en de fr
  • Language selection
  • English
  • Deutsch
  • Français
Main navigation
  • Homepage
    • Go back
    • New to patents
  • New to patents
    • Go back
    • Overview
    • Your business and patents
    • Why do we have patents?
    • What's your big idea?
    • Are you ready?
    • What to expect
    • How to apply for a patent
    • Is it patentable?
    • Are you first?
    • Patent quiz
    • Unitary patent video
  • Searching for patents
    • Go back
    • Overview
    • Technical information
      • Go back
      • Overview
      • Espacenet - patent search
        • Go back
        • Overview
        • National patent office databases
        • Global Patent Index (GPI)
        • Release notes
      • European Publication Server
        • Go back
        • Overview
        • Release notes
        • Cross-reference index for Euro-PCT applications
        • EP authority file
        • Help
      • EP full-text search
    • Legal information
      • Go back
      • Overview
      • European Patent Register
        • Go back
        • Overview
        • Release notes archive
        • Register documentation
          • Go back
          • Overview
          • Deep link data coverage
          • Federated Register
          • Register events
      • European Patent Bulletin
        • Go back
        • Overview
        • Download Bulletin
        • EP Bulletin search
        • Help
      • European Case Law Identifier sitemap
      • Third-party observations
    • Business information
      • Go back
      • Overview
      • PATSTAT
      • IPscore
        • Go back
        • Release notes
      • Technology insight reports
    • Data
      • Go back
      • Overview
      • Technology Intelligence Platform
      • Linked open EP data
      • Bulk data sets
        • Go back
        • Overview
        • Manuals
        • Sequence listings
        • National full-text data
        • European Patent Register data
        • EPO worldwide bibliographic data (DOCDB)
        • EP full-text data
        • EPO worldwide legal event data (INPADOC)
        • EP bibliographic data (EBD)
        • Boards of Appeal decisions
      • Web services
        • Go back
        • Overview
        • Open Patent Services (OPS)
        • European Publication Server web service
      • Coverage, codes and statistics
        • Go back
        • Weekly updates
        • Updated regularly
    • Technology platforms
      • Go back
      • Overview
      • Digital agriculture
        • Go back
        • Overview
        • Plant agriculture
        • Artificial growth conditions
        • Livestock management
        • Supporting technologies
      • Plastics in transition
        • Go back
        • Overview
        • Plastics waste recovery
        • Plastics waste recycling
        • Alternative plastics
      • Innovation in water technologies
        • Go back
        • Overview
        • Clean water
        • Protection from water
      • Space innovation
        • Go back
        • Overview
        • Cosmonautics
        • Space observation
      • Technologies combatting cancer
        • Go back
        • Overview
        • Prevention and early detection
        • Diagnostics
        • Therapies
        • Wellbeing and aftercare
      • Firefighting technologies
        • Go back
        • Overview
        • Detection and prevention of fires
        • Fire extinguishing
        • Protective equipment
        • Post-fire restoration
      • Clean energy technologies
        • Go back
        • Overview
        • Renewable energy
        • Carbon-intensive industries
        • Energy storage and other enabling technologies
      • Fighting coronavirus
        • Go back
        • Overview
        • Vaccines and therapeutics
          • Go back
          • Overview
          • Vaccines
          • Overview of candidate therapies for COVID-19
          • Candidate antiviral and symptomatic therapeutics
          • Nucleic acids and antibodies to fight coronavirus
        • Diagnostics and analytics
          • Go back
          • Overview
          • Protein and nucleic acid assays
          • Analytical protocols
        • Informatics
          • Go back
          • Overview
          • Bioinformatics
          • Healthcare informatics
        • Technologies for the new normal
          • Go back
          • Overview
          • Devices, materials and equipment
          • Procedures, actions and activities
          • Digital technologies
        • Inventors against coronavirus
    • Helpful resources
      • Go back
      • Overview
      • First time here?
        • Go back
        • Overview
        • Basic definitions
        • Patent classification
          • Go back
          • Overview
          • Cooperative Patent Classification (CPC)
        • Patent families
          • Go back
          • Overview
          • DOCDB simple patent family
          • INPADOC extended patent family
        • Legal event data
          • Go back
          • Overview
          • INPADOC classification scheme
      • Asian patent information
        • Go back
        • Overview
        • China (CN)
          • Go back
          • Overview
          • Facts and figures
          • Grant procedure
          • Numbering system
          • Useful terms
          • Searching in databases
        • Taiwan, Province of China (TW)
          • Go back
          • Overview
          • Grant procedure
          • Numbering system
          • Useful terms
          • Searching in databases
        • India (IN)
          • Go back
          • Overview
          • Facts and figures
          • Grant procedure
          • Numbering system
        • Japan (JP)
          • Go back
          • Overview
          • Facts and figures
          • Grant procedure
          • Numbering system
          • Useful terms
          • Searching in databases
        • Korea (KR)
          • Go back
          • Overview
          • Facts and figures
          • Grant procedure
          • Numbering system
          • Useful terms
          • Searching in databases
        • Useful links
      • Patent information centres (PATLIB)
      • Patent Translate
      • Patent Knowledge News
      • Business and statistics
      • Unitary Patent information in patent knowledge
  • Applying for a patent
    • Go back
    • Overview
    • European route
      • Go back
      • Overview
      • European Patent Guide
      • Oppositions
      • Oral proceedings
        • Go back
        • Oral proceedings calendar
          • Go back
          • Calendar
          • Public access to appeal proceedings
          • Public access to opposition proceedings
          • Technical guidelines
      • Appeals
      • Unitary Patent & Unified Patent Court
        • Go back
        • Overview
        • Unitary Patent
          • Go back
          • Overview
          • Legal framework
          • Main features
          • Applying for a Unitary Patent
          • Cost of a Unitary Patent
          • Translation and compensation
          • Start date
          • Introductory brochures
        • Unified Patent Court
      • National validation
      • Extension/validation request
    • International route
      • Go back
      • Overview
      • Euro-PCT Guide
      • Entry into the European phase
      • Decisions and notices
      • PCT provisions and resources
      • Extension/validation request
      • Reinforced partnership programme
      • Accelerating your PCT application
      • Patent Prosecution Highway (PPH)
        • Go back
        • Patent Prosecution Highway (PPH) programme outline
      • Training and events
    • National route
    • MyEPO services
      • Go back
      • Overview
      • Understand our services
        • Go back
        • Overview
        • Exchange data with us using an API
          • Go back
          • Release notes
      • Get access
        • Go back
        • Overview
        • Release notes
      • File with us
        • Go back
        • Overview
        • What if our online filing services are down?
        • Release notes
      • Interact with us on your files
        • Go back
        • Release notes
      • Online Filing & fee payment outages
    • Fees
      • Go back
      • Overview
      • European fees (EPC)
        • Go back
        • Overview
        • Decisions and notices
      • International fees (PCT)
        • Go back
        • Reduction in fees
        • Fees for international applications
        • Decisions and notices
        • Overview
      • Unitary Patent fees (UP)
        • Go back
        • Overview
        • Decisions and notices
      • Fee payment and refunds
        • Go back
        • Overview
        • Payment methods
        • Getting started
        • FAQs and other documentation
        • Technical information for batch payments
        • Decisions and notices
        • Release notes
      • Warning
      • Fee Assistant
      • Fee reductions and compensation
        • Go back
        • Fee support scheme insights
    • Forms
      • Go back
      • Overview
      • Request for examination
    • Find a professional representative
  • Law & practice
    • Go back
    • Overview
    • Legal texts
      • Go back
      • Overview
      • European Patent Convention
        • Go back
        • Overview
        • Archive
          • Go back
          • Overview
          • Documentation on the EPC revision 2000
            • Go back
            • Overview
            • Diplomatic Conference for the revision of the EPC
            • Travaux préparatoires
            • New text
            • Transitional provisions
            • Implementing regulations to the EPC 2000
            • Rules relating to Fees
            • Ratifications and accessions
          • Travaux Préparatoires EPC 1973
      • Official Journal
      • Guidelines
        • Go back
        • Overview
        • EPC Guidelines
        • PCT-EPO Guidelines
        • Unitary Patent Guidelines
        • Guidelines revision cycle
        • Consultation results
        • Summary of user responses
        • Archive
      • Extension / validation system
      • London Agreement
      • National law relating to the EPC
        • Go back
        • Overview
        • Archive
      • Unitary Patent system
        • Go back
        • Travaux préparatoires to UP and UPC
      • National measures relating to the Unitary Patent 
      • International treaties
    • Court practices
      • Go back
      • Overview
      • European Patent Judges' Symposium
    • User consultations
      • Go back
      • Overview
      • Ongoing consultations
      • Completed consultations
    • Substantive patent law harmonisation
      • Go back
      • Overview
      • The Tegernsee process
      • Group B+
    • Convergence of practice
    • Options for representatives
  • News & events
    • Go back
    • Overview
    • News
    • Events
    • European Inventor Award
      • Go back
      • Overview
      • About the award
      • Categories and prizes
      • Meet the inventors
      • Nominations
      • European Inventor Network
        • Go back
        • Overview
        • 2026 activities
        • 2025 activities
        • 2024 activities
        • Rules and criteria
        • FAQ
      • The 2024 event
    • Young Inventors Prize
      • Go back
      • Overview
      • About the prize
      • Nominations
      • The jury
      • The world, reimagined
      • The 2025 event
    • Press centre
      • Go back
      • Overview
      • Patent Index and statistics
      • Search in press centre
      • Background information
        • Go back
        • Overview
        • European Patent Office
        • Q&A on patents related to coronavirus
        • Q&A on plant patents
      • Copyright
      • Press contacts
      • Call back form
      • Email alert service
    • In focus
      • Go back
      • Overview
      • CodeFest
        • Go back
        • CodeFest 2026 on patent and IP portfolio (e)valuation
        • CodeFest Spring 2025 on classifying patent data for sustainable development
        • Overview
        • CodeFest 2024 on generative AI
        • CodeFest 2023 on Green Plastics
      • Green tech in focus
        • Go back
        • Overview
        • About green tech
        • Renewable energies
        • Energy transition technologies
        • Building a greener future
      • Research institutes
      • Lifestyle
      • Space and satellites
        • Go back
        • Overview
        • Patents and space technologies
      • Healthcare
        • Go back
        • Overview
        • Medical technologies and cancer
        • Future of medicine: Personalised medicine
      • Materials science
        • Go back
        • Overview
        • Nanotechnology
      • Mobile communications
      • Biotechnology
        • Go back
        • Overview
        • Red, white or green
        • The role of the EPO
        • What is patentable?
        • Biotech inventors
      • Classification
        • Go back
        • Overview
        • Nanotechnology
        • Climate change mitigation technologies
          • Go back
          • Overview
          • External partners
          • Updates on Y02 and Y04S
      • Digital technologies
        • Go back
        • Overview
        • About ICT
        • Hardware and software
        • Artificial intelligence
        • Fourth Industrial Revolution
      • Additive manufacturing
        • Go back
        • Overview
        • About AM
        • AM innovation
      • Books by EPO experts
    • Podcast
  • Learning
    • Go back
    • Overview
    • Learning activities and paths
      • Go back
      • Overview
      • Learning activities: types and formats
      • Learning paths
    • EQE and EPAC
      • Go back
      • Overview
      • EQE - European Qualifying Examination
        • Go back
        • Overview
        • Compendium
          • Go back
          • Overview
          • Paper F
          • Paper A
          • Paper B
          • Paper C
          • Paper D
          • Pre-examination
        • Candidates successful in the European qualifying examination
        • Archive
      • EPAC - European patent administration certification
      • CSP – Candidate Support Programme
    • Learning resources by area of interest
      • Go back
      • Overview
      • Patent granting
      • Technology transfer and dissemination
      • Patent enforcement and litigation
    • Learning resources by profile
      • Go back
      • Overview
      • Business and IP managers
        • Go back
        • Overview
        • Innovation case studies
          • Go back
          • Overview
          • SME case studies
          • Technology transfer case studies
          • High-growth technology case studies
        • Inventor's handbook
          • Go back
          • Overview
          • Introduction
          • Disclosure and confidentiality
          • Novelty and prior art
          • Competition and market potential
          • Assessing the risk ahead
          • Proving the invention
          • Protecting your idea
          • Building a team and seeking funding
          • Business planning
          • Finding and approaching companies
          • Dealing with companies
        • Best of search matters
          • Go back
          • Overview
          • Tools and databases
          • EPO procedures and initiatives
          • Search strategies
          • Challenges and specific topics
        • Support for high-growth technology businesses
          • Go back
          • Overview
          • Business decision-makers
          • IP professionals
          • Stakeholders of the Innovation Ecosystem
      • EQE and EPAC Candidates
        • Go back
        • Overview
        • Paper F brain-teasers
        • European qualifying examination - Guide for preparation
        • EPAC
      • Judges, lawyers and prosecutors
        • Go back
        • Overview
        • Compulsory licensing in Europe
        • The jurisdiction of European courts in patent disputes
      • National offices and IP authorities
        • Go back
        • Overview
        • Learning material for examiners of national officers
        • Learning material for formalities officers and paralegals
      • Patent attorneys and paralegals
      • Universities, research centres and TTOs
        • Go back
        • Overview
        • Modular IP Education Framework (MIPEF)
        • Pan-European Seal Young Professionals Programme
          • Go back
          • Overview
          • For students
          • For universities
            • Go back
            • Overview
            • IP education resources
            • University memberships
          • Our young professionals
          • Professional development plan
        • Academic Research Programme
          • Go back
          • Overview
          • Completed research projects
          • Current research projects
        • IP Teaching Kit
          • Go back
          • Overview
          • Download modules
        • Intellectual property course design manual
        • PATLIB Knowledge Transfer to Africa
          • Go back
          • Core activities
          • Stories and insights
  • About us
    • Go back
    • Overview
    • The EPO at a glance
    • 50 years of the EPC
      • Go back
      • Official celebrations
      • Overview
      • Member states’ video statements
        • Go back
        • Albania
        • Austria
        • Belgium
        • Bulgaria
        • Croatia
        • Cyprus
        • Czech Republic
        • Denmark
        • Estonia
        • Finland
        • France
        • Germany
        • Greece
        • Hungary
        • Iceland
        • Ireland
        • Italy
        • Latvia
        • Liechtenstein
        • Lithuania
        • Luxembourg
        • Malta
        • Monaco
        • Montenegro
        • Netherlands
        • North Macedonia
        • Norway
        • Poland
        • Portugal
        • Romania
        • San Marino
        • Serbia
        • Slovakia
        • Slovenia
        • Spain
        • Sweden
        • Switzerland
        • Türkiye
        • United Kingdom
      • 50 Leading Tech Voices
      • Athens Marathon
      • Kids’ collaborative art competition
    • Legal foundations and member states
      • Go back
      • Overview
      • Legal foundations
      • Member states
        • Go back
        • Overview
        • Member states by date of accession
      • Extension states
      • Validation states
    • Administrative Council and subsidiary bodies
      • Go back
      • Overview
      • Communiqués
        • Go back
        • 2024
        • Overview
        • 2023
        • 2022
        • 2021
        • 2020
        • 2019
        • 2018
        • 2017
        • 2016
        • 2015
        • 2014
        • 2013
      • Calendar
      • Documents and publications
      • Administrative Council
        • Go back
        • Overview
        • Composition
        • Representatives
        • Rules of Procedure
        • Board of Auditors
        • Secretariat
        • Council bodies
    • Principles & strategy
      • Go back
      • Overview
      • Mission, vision, values & corporate policy
      • Strategic Plan 2028
        • Go back
        • Driver 1: People
        • Driver 2: Technologies
        • Driver 3: High-quality, timely products and services
        • Driver 4: Partnerships
        • Driver 5: Financial sustainability
      • Towards a New Normal
      • Data protection & privacy notice
    • Leadership & management
      • Go back
      • Overview
      • About the President
      • Management Advisory Committee
    • Sustainability at the EPO
      • Go back
      • Overview
      • Environmental
        • Go back
        • Overview
        • Inspiring environmental inventions
      • Social
        • Go back
        • Overview
        • Inspiring social inventions
      • Governance and Financial sustainability
    • Procurement
      • Go back
      • Overview
      • Procurement forecast
      • Doing business with the EPO
      • Procurement procedures
      • Dynamic Purchasing System (DPS) publications
      • Sustainable Procurement Policy
      • About eTendering
      • Invoicing
      • Procurement portal
        • Go back
        • Overview
        • e-Signing contracts
      • General conditions
      • Archived tenders
    • Services & activities
      • Go back
      • Overview
      • Our services & structure
      • Quality
        • Go back
        • Overview
        • Foundations
          • Go back
          • Overview
          • European Patent Convention
          • Guidelines for examination
          • Our staff
        • Enabling quality
          • Go back
          • Overview
          • Prior art
          • Classification
          • Tools
          • Processes
        • Products & services
          • Go back
          • Overview
          • Search
          • Examination
          • Opposition
          • Continuous improvement
        • Quality through networking
          • Go back
          • Overview
          • User engagement
          • Co-operation
          • User satisfaction survey
          • Stakeholder Quality Assurance Panels
        • Patent Quality Charter
        • Quality Action Plan
        • Quality dashboard
        • Statistics
          • Go back
          • Overview
          • Search
          • Examination
          • Opposition
        • Integrated management at the EPO
      • Consulting our users
        • Go back
        • Overview
        • Standing Advisory Committee before the EPO (SACEPO)
          • Go back
          • Overview
          • Objectives
          • SACEPO and its working parties
          • Meetings
          • Single Access Portal – SACEPO Area
        • Surveys
          • Go back
          • Overview
          • Detailed methodology
          • Search services
          • Examination services, final actions and publication
          • Opposition services
          • Formalities services
          • Customer services
          • Filing services
          • Key Account Management (KAM)
          • Website
          • Archive
      • Our user service charter
      • European and international co-operation
        • Go back
        • Overview
        • Co-operation with member states
          • Go back
          • Overview
        • Bilateral co-operation with non-member states
          • Go back
          • Overview
          • Validation system
          • Reinforced Partnership programme
        • Multilateral international co-operation with IP offices and organisations
        • Co-operation with international organisations outside the IP system
      • European Patent Academy
        • Go back
        • Overview
        • Partners
      • Chief Economist
        • Go back
        • Overview
        • Economic studies
      • Ombuds Office
      • Reporting wrongdoing
    • Observatory on Patents and Technology
      • Go back
      • Overview
      • Technologies
        • Go back
        • Overview
        • Innovation against cancer
        • Assistive robotics
        • Energy enabling technologies
          • Go back
          • Overview
          • Publications
        • Energy generation technologies
        • Water technologies
        • Plastics in transition
        • Space technologies
        • Digital agriculture
      • Innovation actors
        • Go back
        • Overview
        • Startups and SMEs
          • Go back
          • Overview
          • Publications
        • Research universities and public research organisations
        • Women inventors
      • Policy and funding
        • Go back
        • Overview
        • Financing innovation programme
          • Go back
          • Overview
          • Our studies on the financing of innovation
          • EPO initiatives for patent applicants
          • Financial support for innovators in Europe
        • Patents and standards
          • Go back
          • Overview
          • Publications
          • Patent standards explorer
      • Observatory tools
        • Go back
        • Overview
        • Deep Tech Finder
        • Digital Library on Innovation
          • Go back
          • Overview
          • Become a contributor to the Digital Library
      • About the Observatory
        • Go back
        • Overview
        • Work plan
        • Collaboration with European actors
    • Transparency portal
      • Go back
      • Overview
      • General
        • Go back
        • Overview
        • Annual Review 2024
          • Go back
          • Overview
          • Executive summary
          • Driver 1 – People
          • Driver 2 – Technologies
          • Driver 3 – High-quality, timely products and services
          • Driver 4 – Partnerships
          • Driver 5 – Financial Sustainability
        • Annual Review 2023
          • Go back
          • Overview
          • Foreword
          • Executive summary
          • 50 years of the EPC
          • Strategic key performance indicators
          • Goal 1: Engaged and empowered
          • Goal 2: Digital transformation
          • Goal 3: Master quality
          • Goal 4: Partner for positive impact
          • Goal 5: Secure sustainability
        • Annual Review 2022
          • Go back
          • Overview
          • Foreword
          • Executive summary
          • Goal 1: Engaged and empowered
          • Goal 2: Digital transformation
          • Goal 3: Master quality
          • Goal 4: Partner for positive impact
          • Goal 5: Secure sustainability
      • Human
      • Environmental
      • Organisational
      • Social and relational
      • Economic
      • Governance
    • Statistics and trends
      • Go back
      • Overview
      • Statistics & Trends Centre
      • Patent Index 2024
        • Go back
        • Insight into computer technology and AI
        • Insight into clean energy technologies
        • Statistics and indicators
          • Go back
          • European patent applications
            • Go back
            • Key trend
            • Origin
            • Top 10 technical fields
              • Go back
              • Computer technology
              • Electrical machinery, apparatus, energy
              • Digital communication
              • Medical technology
              • Transport
              • Measurement
              • Biotechnology
              • Pharmaceuticals
              • Other special machines
              • Organic fine chemistry
            • All technical fields
          • Applicants
            • Go back
            • Top 50
            • Categories
            • Women inventors
          • Granted patents
            • Go back
            • Key trend
            • Origin
            • Designations
      • Data to download
      • EPO Data Hub
      • Clarification on data sources
    • History
      • Go back
      • Overview
      • 1970s
      • 1980s
      • 1990s
      • 2000s
      • 2010s
      • 2020s
    • Art collection
      • Go back
      • Overview
      • The collection
      • Let's talk about art
      • Artists
      • Media library
      • What's on
      • Publications
      • Contact
      • Culture Space A&T 5-10
        • Go back
        • Overview
        • Catalyst lab & Deep vision
          • Go back
          • Overview
          • Irene Sauter (DE)
          • AVPD (DK)
          • Jan Robert Leegte (NL)
          • Jānis Dzirnieks (LV) #1
          • Jānis Dzirnieks (LV) #2
          • Péter Szalay (HU)
          • Thomas Feuerstein (AT)
          • Tom Burr (US)
          • Wolfgang Tillmans (DE)
          • TerraPort
          • Unfinished Sculpture - Captives #1
          • Deep vision – immersive exhibition
          • Previous exhibitions
        • The European Patent Journey
        • Sustaining life. Art in the climate emergency
        • Next generation statements
        • Open storage
        • Cosmic bar
      • "Long Night"
  • Boards of Appeal
    • Go back
    • Overview
    • Decisions of the Boards of Appeal
      • Go back
      • Overview
      • Recent decisions
      • Selected decisions
    • Information from the Boards of Appeal
    • Procedure
    • Oral proceedings
    • About the Boards of Appeal
      • Go back
      • Overview
      • President of the Boards of Appeal
      • Enlarged Board of Appeal
        • Go back
        • Overview
        • Pending referrals (Art. 112 EPC)
        • Decisions and opinions (Art. 112 EPC)
        • Pending petitions for review (Art. 112a EPC)
        • Decisions on petitions for review (Art. 112a EPC)
      • Technical Boards of Appeal
      • Legal Board of Appeal
      • Disciplinary Board of Appeal
      • Presidium
        • Go back
        • Overview
    • Code of Conduct
    • Business distribution scheme
      • Go back
      • Overview
      • Technical boards of appeal by IPC in 2025
      • Archive
    • Annual list of cases
    • Communications
    • Annual reports
      • Go back
      • Overview
    • Publications
      • Go back
      • Abstracts of decisions
    • Case Law of the Boards of Appeal
      • Go back
      • Overview
      • Archive
  • Service & support
    • Go back
    • Overview
    • Website updates
    • Availability of online services
      • Go back
      • Overview
    • FAQ
      • Go back
      • Overview
    • Publications
    • Ordering
      • Go back
      • Overview
      • Patent Knowledge Products and Services
      • Terms and conditions
        • Go back
        • Overview
        • Patent information products
        • Bulk data sets
        • Open Patent Services (OPS)
        • Fair use charter
    • Procedural communications
    • Useful links
      • Go back
      • Overview
      • Patent offices of member states
      • Other patent offices
      • Directories of patent attorneys
      • Patent databases, registers and gazettes
      • Disclaimer
    • Contact us
      • Go back
      • Overview
      • Filing options
      • Locations
    • Subscription centre
      • Go back
      • Overview
      • Subscribe
      • Change preferences
      • Unsubscribe
    • Official holidays
    • Glossary
    • RSS feeds
Board of Appeals
Decisions

Recent decisions

Overview
  • 2025 decisions
  • 2024 decisions
  • 2023 decisions
  1. Home
  2. T 0846/22 30-07-2024
Facebook X Linkedin Email

T 0846/22 30-07-2024

European Case Law Identifier
ECLI:EP:BA:2024:T084622.20240730
Date of decision
30 July 2024
Case number
T 0846/22
Petition for review of
-
Application number
16191743.0
IPC class
A61M 15/00
Language of proceedings
EN
Distribution
NO DISTRIBUTION (D)

Download and more information:

Decision in EN 766.99 KB
Documentation of the appeal procedure can be found in the European Patent Register
Bibliographic information is available in:
EN
Versions
Unpublished
Application title

METERED DOSE INHALER FOR DISPENSING AEROSOL DOSES

Applicant name
Presspart GmbH & Co. KG
Opponent name
European Oppositions Limited
Board
3.2.02
Headnote
-
Relevant legal provisions
European Patent Convention Art 56
European Patent Convention Art 58
European Patent Convention Art 83
European Patent Convention Art 99(1)
European Patent Convention Art 104(1)
Section 1169 UK Companies Act 2006
Keywords

Admissibility of opposition - acting on behalf of a third party - entitlement to file an opposition (yes)

Sufficiency of disclosure - (yes)

Inventive step - (yes)

Apportionment of costs - abuse of procedure

Apportionment of costs - (no)

Catchword
-
Cited decisions
G 0003/97
G 0003/99
G 0001/13
T 0475/07
T 0184/11
Citing decisions
-

I. The opponent appealed against the Opposition Division's decision that, account being taken of the amendments made by the patent proprietor during the opposition proceedings according to auxiliary request 1, the European patent and the invention to which it relates met the requirements of the EPC.

II. The Board summoned the parties to oral proceedings and provided its preliminary opinion.

III. By letter of 29 July 2024, the appellant informed the Board that it would not attend the oral proceedings.

IV. Oral proceedings took place on 30 July 2024 without the appellant.

The appellant had requested in writing that the decision under appeal be set aside and that the patent be revoked.

The respondent requested that the decision under appeal be set aside and the opposition be held inadmissible. They also requested that the appeal be rejected as inadmissible, or that the appeal be dismissed. In the alternative, the respondent requested that the patent be maintained on the basis of one of auxiliary requests 1 to 4 filed with the reply to the statement setting out the grounds of appeal. Furthermore, they requested that the appellant be ordered to pay the respondent's costs arising from participation in the opposition and appeal proceedings (first request for apportionment of costs) and that the appellant be ordered to pay the respondent's costs for the preparation of the oral proceedings in view of the appellant's non-attendance at the oral proceedings (second request for apportionment of costs).

V. The following documents are mentioned in this decision:

D1: GB 2506385 A

D2: WO 2016/030844 A1

D3: WO 2005/009325 A2

VI. Claim 1 of the request found allowable by the Opposition Division reads as follows:

"Metered dose inhaler for dispensing aerosol doses comprising:

an actuation housing (2) adapted to receive a canister (4) which is configured to move from a rest position to an activation position in which a valve (7) of the canister (4), positioned at a valve end (8) of the canister (4), is depressed against a bottom portion (9) of the actuation housing (2) such that an aerosol dose is released,

a mechanical dose counter (10) comprising an indicator member which is constructed and arranged to undergo a predetermined count-indicating motion when an aerosol dose is released,

a triggering unit (11, 11', 11'', 11''') for triggering at least one electrical switch (12) when the canister (4) is moved from the rest position to the activation position, whereby an electrical signal is generated, and

a processing unit (19) for processing the signal generated by the switch (12) upon being triggered,

wherein the actuation housing (2) further comprises a mouthpiece (3) for inhalation of the aerosol,

characterized in

that the triggering unit (11, 11', 11'', 11''') is positioned within the actuation housing (2) opposite to the mouthpiece (3), wherein the actuation housing (2) is adapted to receive the canister (4) in between the triggering unit (11, 11', 11'', 11''') and the mouthpiece (3) and,

that the triggering unit (11, 11', 11'', 11''') comprises trigger members (13, 13a, 13b) for triggering the at least one electrical switch (12), wherein the trigger members (13, 13a, 13b) are designed as flexible tongues (14) each having an end portion (15)."

Claims 2 to 12 are dependent claims.

VII. The appellant's arguments relevant to this decision can be summarised as follows.

Admissibility of the appeal

The appeal had been filed and the appeal fee paid in timely manner. The appeal was admissible.

Sufficiency of disclosure

The invention as defined in claim 1 of the request found allowable by the Opposition Division was not sufficiently disclosed. The patent only disclosed an arrangement with two trigger members which operated on two respective switches. There was neither any teaching nor any pointer or suggestion in the patent for the person skilled in the art about the possibility of implementing any different arrangements, for example arrangements including any arbitrary combination of two or more trigger members with two or more switches, such arrangements being covered by claim 1 of the request found allowable by the Opposition Division.

Inventive step

The subject-matter of claim 1 of the request found allowable by the Opposition Division lacked an inventive step when starting from D1, in combination with common general knowledge or D2, and when starting from D2, in combination with common general knowledge, D1 and/or D3. Moreover, some documents which the Opposition Division had not admitted into the proceedings should be admitted into the appeal proceedings.

Starting from D1, the provision of a plurality of trigger members could be regarded as a minimal constructional variation. Electromechanical actuator 202 shown in Figure 2 of D1 was essentially the same or equivalent to at least one of the flexible tongues required by claim 1. The objective technical problem should be formulated as being how to provide an alternative configuration or design for any trigger members.

The provision of a plurality of trigger members as claimed was therefore obvious from the common general knowledge of the person skilled in the art.

Moreover, maintaining compactness was not the specific purpose of D1, which only referred to "compact size" in paragraph [0007], on page 2. Maintaining compactness was, at most, a general goal in the inhaler industry. The fundamental purpose of D1 was to minimise power requirements for recording inhaler events. The triggering units of D1 and D2 were intrinsically similar, D2 was as concerned about dose monitoring as D1 and there was no reason to believe that a modification of D1 based on D2 would undermine the lower power consumption goals of D1. It followed that D1 and D2 were compatible and combinable in an obvious way.

Starting from D2, the provision of a mechanical dose counter comprising an indicator member which is constructed and arranged to undergo a predetermined count-indicating motion when an aerosol dose is released was obvious in view of common general knowledge. Claim 1 did not specify the location of the mechanical dose counter, and therefore this feature could not justify an inventive step in synergy with the feature of the trigger unit with the triggering members. Moreover, D1 taught the provision of a mechanical dose counter as claimed. Mechanical dose counters and electric/electronic dose counters could well coexist in compact inhalers, and mechanical dose counters could be located at locations entirely different from that of D1. If need be, the person skilled in the art would have adapted the housing, canister and trigger unit of D1 in view of the teaching of D3.

VIII. The respondent's arguments relevant to this decision can be summarised as follows.

Admissibility of the opposition and the appeal

The admissibility of the opposition had to be examined ex officio in every phase of the opposition and ensuing appeal proceedings. The opposition in the current case had to be considered inadmissible since the appellant, a UK company, was a "dormant company" and had been a "dormant company" at the time of filing the opposition. Under UK law, a company or association could be "dormant" if it was not doing business and did not have any other income, for example investments, as defined by Section 455 of the UK Companies Act.

The appellant had not been entitled to conduct any business and had not been active at the time of filing the opposition, during the entire opposition proceeding and even at the time when the appeal was filed. Hence, it could not be equated to a legal person.

Moreover, the opposition should be considered inadmissible because the appellant's involvement in the case had to be regarded as circumventing the law by abuse of procedure, and as a dormant company the appellant could not have appointed and paid any authorised representative to act on its behalf, as this would have meant acting beyond its allowed transactions.

Although the fact that the appellant was acting on behalf of a third party did not, as such, render the opposition inadmissible, it was evident that the opposition had been filed in the name of a dormant company to avoid any liability on the part of the real opponent for any possible costs in the event of the Opposition Division ordering a different apportionment of costs in favour of the respondent for reasons of equity. Circumventing possible remedies given to the parties by Article 104 EPC amounted to an abuse of procedure and so rendered the opposition inadmissible per se.

Furthermore, the acts of filing an opposition and appointing a representative were beyond the transactions allowed for a dormant company. For this reason, it was highly questionable whether a representative could be properly authorised. No power of attorney had in fact been filed. Hence, it had to be assumed that the opposition had been filed by a non-authorised representative, which also rendered the opposition inadmissible. As a consequence, the appeal was inadmissible too.

The current case was different from the case underlying T 184/11, in which the opponent was not acting as a straw man for others and the representative had been empowered.

Sufficiency of disclosure

The invention as defined in claim 1 of the request found allowable by the Opposition Division was sufficiently disclosed. The patent disclosed an embodiment with two trigger members and two switches. On the basis of the teaching of the patent as a whole, the person skilled in the art would have been able to carry out the invention for the possible combinations of the number of trigger members and the electrical switches that were covered by the wording of the claim.

Inventive step

The subject-matter of claim 1 of the request found allowable by the Opposition Division was inventive in view of D1 to D3. The appellant had not discussed in detail other documents which the Opposition Division had not admitted into the proceedings.

Starting from D1, this document did not disclose a triggering unit that comprised trigger members for triggering at least one electrical switch, wherein the trigger members were designed as flexible tongues each having an end portion.

The technical effect of these distinguishing features was that the trigger members were reliably deflected upon vertical movement of the canister and were thus able to reliably trigger the switches while at the same time the vertical movement of the canister was not impeded.

Neither D1 nor common general knowledge provided any prompting towards the distinguishing features for providing the technical effect.

Moreover, the person skilled in the art would have had no reason to implement the trigger members together with the electrical switches disclosed in D2 in the inhaler according to D1.

According to D1, it was necessary to maintain the compact size of dispensing devices (paragraph [0007]). It was also desirable to minimise the need for regulatory approval, which required any device recording usage patterns and time of usage to have minimal power requirements to mitigate the need for larger power sources or complex circuitry and additional cost (paragraph [0007]). Moreover, according to D1, the small footprint of the event recordal device allowed conventional inhalers to be used without any modifications (paragraph [0061]). Implementing the trigger members according to D2 in the inhaler according to D1 would have gone against the requirements of maintaining a compact size and minimal power consumption of the event recordal device according to D1.

Thus, the person skilled in the art, starting from D1, would not have combined the teachings of D1 and D2.

Starting from D2, this document did not disclose a mechanical dose counter comprising an indicator member constructed and arranged to undergo a predetermined count-indicating motion when an aerosol dose is released.

The effect of the distinguishing features was that the dose counting function was reliably provided by the mechanical dose counter wherein additional functions such as monitoring or evaluation functions could be realised by the additional triggering unit as well as the processing unit (paragraph [0012] of the patent).

Thus, the objective technical problem can be formulated as providing a metered dose inhaler with a reliable dose counting function as well as additional functions such as monitoring functions (paragraph [0009] of the patent).

In view of common general knowledge, D1 and/or D3, the person skilled in the art would not have arrived at the subject-matter of claim 1 of the request found allowable by the Opposition Division without an inventive step. D1 and D2 taught that mechanical dose counters added significant costs and could be inaccurate (paragraph [0004] of D1 and [0005] of D2). D3 did not disclose a mechanical dose counter.

Requests for apportionment of costs

The respondent's costs from the first and second instance proceedings were to be charged to the appellant and a corresponding order to apportion costs was to be issued, because these costs were incurred culpably by the appellant's abuse of procedure with the aim of circumventing possible remedies given to the parties by Article 104 EPC.

Moreover, in view of T 475/07, the respondent's costs incurred for the preparation of the oral proceedings before the Board had to be charged to the appellant, because it was only the evening before that it had informed the Board of its intention not to participate in the oral proceedings. The appellant had not in any way informed the respondent. Had the respondent been informed, the costs for the preparation of at least part of the oral proceedings would not have been incurred, in view of the Board's preliminary opinion, which was favourable to the respondent in respect of a number of issues.

1. Admissibility of the opposition and the appeal

The respondent argued that the opposition and the appeal were not admissible.

1.1 It submitted that the appellant, a UK company, had been a "dormant company" under UK law at the time of filing the opposition and had never changed this status. This meant that the appellant was not entitled to conduct any business and could not be equated to a legal person.

Under Article 99(1) EPC "any person may give notice to the European Patent Office of opposition [ ... ] in accordance with the Implementing Regulations". "Any person" is to be interpreted in line with Article 58 EPC as "any natural or legal person, or any body equivalent to a legal person by virtue of the law governing it" (G 3/99, point 9 of the Reasons, G 1/13 point 2.3.3 of the Reasons).

The status of a legal person as such, i.e. the question as to whether it has capacity to sue or be sued, is a matter of national law. The right to bring opposition proceedings, to take part in such proceedings, to file an appeal and to take part in appeal proceedings is, by contrast, a matter of procedural law governed by the EPC (G 1/13, ooint 5.3 of the Reasons with reference to G 3/97, point 2.1 of the Reasons).

The respondent questioned the status of the appellant as a legal person as such. Hence, it has to be established whether the appellant, the company European Oppositions Limited, in particular at the time of filing the notice of opposition and the notice of appeal, had the status of a legal person.

Section 1169 of the Companies Act 2006 which applies throughout the UK defines a dormant company. A company is dormant during any period in which it has no significant accounting transactions. A dormant company can be reactivated. Engaging in significant transactions may result in a dormant company losing its dormant status.

Although inactive, a dormant company is not struck off, but remains on the Companies House register. This means that a dormant company maintains the status of a legal person. The Board agrees with the conclusion drawn to this effect in T 184/11 (point 2.2 of the Reasons).

It follows that the appellant had the status of a legal person at the time of filing the notice of opposition and throughout the opposition and appeal proceedings. The respondent's argument in this respect is therefore not convincing.

1.2 The respondent also argued that the appellant could not have paid the opposition or the appeal fee and could not have appointed an authorised representative. Moreover, it was evident that the appellant had been acting on behalf of a third party with the intention of avoiding any liability for possible costs apportioned to the appellant under Article 104 EPC. This amounted to an abuse of procedure.

However, whether the appellant engaged in transactions which could have led to the loss of its dormant status goes beyond the assessment of its status as a legal person. The assessment of potential financial relationships between a dormant company and an appointed representative is of no relevance to establishing the legal status of the company as a legal person either.

Moreover, the opponent's representative was appointed in accordance with the requirements of the EPC. Hence, there is no reason for the Board to doubt that the representative was duly authorised. The remaining provisions under the EPC for the admissibility of the opposition and appeal, including the payment of the relevant fees, were also complied with.

As regards the contention that the appellant had been acting on behalf of a third party with the intention of avoiding any liability for possible costs apportioned to the appellant under Article 104 EPC, the Board notes that acting on behalf of a third party cannot be seen as a circumvention of the law unless further circumstances are involved (G 3/97, point 3.2 of the Reasons) and there is no requirement under the EPC that a party be equipped with sufficient financial means to comply with a merely hypothetical costs order. Moreover, the EPC does not offer the patent proprietor any kind of guarantee that an opponent will be able in fact to reimburse costs awarded against him (G 3/97, point 3.2.6 of the Reasons).

For these reasons, the Board does not see any abuse of procedure by the appellant which might render the opposition and/or the appeal inadmissible.

1.3 In conclusion, the respondent's requests that the decision under appeal be set aside and the opposition be held inadmissible or that the appeal be held inadmissible must be refused.

2. The subject-matter of the patent

The patent relates to a metered dose inhaler for dispensing aerosol doses. The doses are to be taken into the body of a patient upon inhalation, via the nose or mouth, and then delivered to the lungs. Metered dose inhalers are typically used for the treatment of respiratory infections and disorders. Asthma treatment is a particularly commonly use (paragraph [0003] of the patent).

A metered dose inhaler according to claim 1 of the request found allowable by the Opposition Division and a triggering unit of the inhaler according to the claim are schematically depicted in Figures 2 and 3 of the patent, reproduced below.

FORMULA/TABLE/GRAPHICFORMULA/TABLE/GRAPHIC

The claimed metered dose inhaler comprises an actuation housing (2), a mechanical dose counter (10), a triggering unit (11) and a processing unit (19).

The actuation housing comprises a mouthpiece (3) for inhalation of the aerosol and is adapted to receive a canister (4) configured to move from a rest position to an activation position. In the activation position a valve (7) of the canister, positioned at a valve end of the canister, is depressed against a bottom portion (9) of the actuation housing such that an aerosol dose is released.

The mechanical dose counter comprises an indicator member constructed and arranged to undergo a predetermined count indicating motion when an aerosol dose is released.

The triggering unit is positioned within the actuation housing opposite to the mouthpiece and is adapted to receive the canister in between the triggering unit and the mouthpiece. The triggering unit is for triggering at least one electrical switch when the canister is moved from the rest position to the activation position. This generates an electrical signal. The triggering unit also comprises trigger members (13, 13a, 13b) for triggering the at least one electrical switch. The trigger members are designed as flexible tongues each having an end portion.

The processing unit is for processing the signal generated by the switch upon being triggered.

According to the patent (paragraphs [0012] to [0014]) it is advantageous in terms of reliability and energy consumption to have both a mechanical dose counter for the basic counting function and an electrical trigger unit in combination with a processing unit for additional functions such as monitoring or evaluation functions.

3. Sufficiency of disclosure

The appellant argued that the patent only disclosed an arrangement with two trigger members which operated on two respective switches and that there was no teaching about how the skilled person could implement any different arrangements including any arbitrary combination of a plurality of trigger members with a plurality of switches. Hence, the subject-matter of claim 1 of the request found allowable by the Opposition Division was not sufficiently disclosed.

This objection is not convincing. While it is true that the patent discloses in detail embodiments with two trigger members (13) and two switches (12), the person skilled in the art would have known how to provide other combinations of trigger members and switches, as this is a matter of common mechanical design. The embodiments shown in Figures 3 to 10 show different arrangements of trigger members which the person skilled in the art would have considered when devising other embodiments as claimed.

It follows that the appellant's objection of lack of sufficiency (Article 83 EPC) does not prejudice maintenance of the patent on the basis of the request found allowable by the Opposition Division.

4. Inventive step

4.1 Starting from D1 in combination with common general knowledge or D2, the appellant argued against claim 1 of the request found allowable by the Opposition Division involving an inventive step.

It is common ground that D1 discloses (Figures 1 and 2 reproduced below and paragraphs [0059] to [0064]) a metered dose inhaler (100) comprising an actuation housing (101) with a mouthpiece (102) and adapted to receive a canister (103), a mechanical dose counter (105), a triggering unit (104) positioned within the actuation housing opposite to the mouthpiece for triggering at least one electrical switch (by a single actuator 202), and a processing unit.

FORMULA/TABLE/GRAPHICFORMULA/TABLE/GRAPHIC

D1 does not disclose that the triggering unit comprises trigger members designed as flexible tongues each having an end portion for triggering the electrical switch.

The technical effect of the distinguishing feature is that more parameters of an actuation can be recorded, such as the speed of actuation of the inhaler (paragraph [0017] of the patent).

This solves the objective technical problem of better monitoring delivery of the aerosol doses to a patient by the triggering unit. The problem formulated by the appellant, i.e. how to provide an alternative configuration or design for any trigger members, is not acceptable as it does not take the technical effect of the distinguishing feature into account.

4.1.1 The person skilled in the art would have had no incentive from common general knowledge to provide more than one trigger member in order to solve the objective technical problem. There is simply no evidence in this respect.

4.1.2 D2 discloses a metered dose inhaler with a triggering unit comprising two trigger members designed as flexible tongues (514 and 516, Figure 4, reproduced below) each having an end portion for triggering electrical switches. Paragraph [0046] teaches that such trigger members make it possible to monitor more parameters of the actuation of the metered dose inhaler.

FORMULA/TABLE/GRAPHIC

While D2 seems to address the problem of providing better monitoring of the delivery of the aerosol doses, it has to be noted that D1 stresses the advantages of the possibility of retrofitting a conventional metered dose inhaler with a triggering unit. The triggering unit, denoted "event recordal device", can be "inserted into a conventional inhaler as an add-on device or module. The small footprint of the event recordal device allows conventional inhalers to be used with no modifications" (paragraph [0061]). Accordingly, D1 teaches that while it is desirable to "provide accurate information regarding the usage patterns and times of the usage" (paragraph [0005]), "it is necessary to maintain the compact size of dispensing devices. It is also desirable to minimize the need for regulatory approval which would increase the costs associated with the device" (paragraph [0007]). Hence, the appellant's argument that maintaining compactness was merely a general goal in the inhaler industry is not convincing. Maintaining compactness is specifically taught as an important requirement by D1.

On the basis of this disclosure, the person skilled in the art would not have implemented the relatively cumbersome triggering unit disclosed in D2 in the metered dose inhaler of D1, because this would have gone against this important requirement taught by D1.

It follows that the appellant's objection of lack of inventive step (Article 56 EPC) starting from D1 is not successful.

4.2 The appellant also argued starting from D2 in combination with common general knowledge, D1 and/or D3.

It is common ground that D2 does not disclose a mechanical dose counter in addition to the triggering unit for triggering electrical switches.

This distinguishing feature addresses the objective technical problem of improving the reliability and energy consumption of a metered dose inhaler. This is because the mechanical dose counter can be used for the basic counting function, and an electrical trigger unit in combination with a processing unit can be used for additional functions such as monitoring or evaluation functions (paragraphs [0012] to [0014] of the patent).

The appellant's argument that the person skilled in the art would have implemented the distinguishing feature in the device of D2 in view of the teaching of D1, common general knowledge or D3 is not convincing. None of D1, common general knowledge or D3 teaches the provision of a mechanical dose counter for solving the objective technical problem. D1 mentions a mechanical dose counter only as a standard component of a conventional metered dose inhaler. D3 does not disclose a mechanical dose counter at all. It is therefore irrelevant whether mechanical dose counters and electric/electronic dose counters could coexist or where a mechanical dose counter could be implemented in the inhaler of D2. The person skilled in the art would not have had any motivation for such implementation.

It follows that the appellant's objection of lack of inventive step (Article 56 EPC) starting from D2 is not successful either.

4.3 In conclusion, the appellant's objections of lack of inventive step (Article 56 EPC) do not prejudice maintenance of the patent on the basis of the request found allowable by the Opposition Division.

In reaching this conclusion, it is of no relevance to establish whether the "at least one electrical switch" is part of the subject-matter of claim 1, as questioned by the appellant.

It is not necessary to consider the admissibility of some documents which the Opposition Division had not admitted into the proceedings either, since the appellant has not raised any objection on the basis of these documents in the appeal proceedings.

5. Requests for apportionment of costs

The respondent requested that the Board apportion some of the costs it had incurred to the appellant.

According to Article 104(1) EPC, each party to the opposition proceedings must bear the costs it has incurred, unless, for reasons of equity, a different apportionment should be ordered.

5.1 The respondent argued that its costs from the first and second instance proceedings should be charged to the appellant because these costs were incurred through an abuse of procedure by the appellant, namely acting throughout the opposition and appeal proceedings whilst being a dormant company.

However, the Board has concluded that there was no abuse of procedure in this respect. It follows that this respondent's request has to be refused.

5.2 The respondent also argued that, in view of T 475/07, its costs incurred for the preparation of the oral proceedings before the Board should be charged to the appellant.

The Board notes that, although it would have been appropriate for the appellant to inform the respondent and the Board of its intention not to participate in the oral proceedings at an earlier time, the oral proceedings would have had to take place anyway. This is because of the respondent's requests for oral proceedings "in the event that the Board of Appeal does not intend to set aside the decision of the first instance" (Reply, point 1). Hence, in contrast to the case underlying T 475/07, the appellant's conduct had no impact on the necessity of holding oral proceedings.

As regards the respondent's argument with reference to the Board's preliminary opinion, it is pointed out that, even when all the parties attend the oral proceedings, it is possible that not all the issues addressed in the preliminary opinion will be discussed, since for some of them the parties may refer to their written submissions. Moreover, the respondent could not be sure that the preliminary opinion, given its preliminary nature, would be maintained in the oral proceedings. Deciding not to be prepared for an issue which could potentially be discussed at the oral proceedings, irrespective of the Board's preliminary view on the issue, always involves some risk and it is the parties' responsibility to decide what to prepare for. In any case, it could not be asserted beforehand that the Board's preliminary opinion would have rendered the oral proceedings unnecessary.

For these reasons, the Board does not consider it equitable to order the apportionment of costs in favour of the respondent. Hence, this request by the respondent has to be refused too.

Order

For these reasons it is decided that:

1. The appeal is dismissed.

2. The requests for apportionment of costs are refused.

Footer - Service & support
  • Service & support
    • Website updates
    • Availability of online services
    • FAQ
    • Publications
    • Procedural communications
    • Contact us
    • Subscription centre
    • Official holidays
    • Glossary
Footer - More links
  • Jobs & careers
  • Press centre
  • Single Access Portal
  • Procurement
  • Boards of Appeal
Facebook
European Patent Office
EPO Jobs
Instagram
EuropeanPatentOffice
Linkedin
European Patent Office
EPO Jobs
EPO Procurement
X (formerly Twitter)
EPOorg
EPOjobs
Youtube
TheEPO
Footer
  • Legal notice
  • Terms of use
  • Data protection and privacy
  • Accessibility